Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 EUR | -0.47% | +2.69% | -49.70% |
30/04 | Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
29/04 | Biosynex: agreement for ProciseDx in North America | CF |
1st Jan change | Capi. | |
---|---|---|
-49.70% | 48.69M | |
-1.89% | 12.56B | |
-9.59% | 7.68B | |
-1.31% | 5.29B | |
+21.82% | 5.24B | |
+0.02% | 4.57B | |
-50.89% | 3.29B | |
+6.42% | 2.6B | |
-10.02% | 2.2B | |
-8.29% | 1.79B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- ProciseDx Inc. announced that it has received $13 million in funding from Biosynex SA, Nestlé HealthCare Nutrition, Inc., and other investors